Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate ... representative in the GLP-1 agonist market to testify at the hearing. Donald Trump's plan to ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of leadership was required amid fierce glucagon-like peptide 1 receptor ...

Jørgensen has agreed to serve as the company’s CEO on an interim basis until his replacement is found. The Danish pharma giant added that Lars Rebien Sørensen, chair of the Novo Nordisk ...

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker on Friday abruptly announced that longtime CEO Lars Fruergaard ...

The Danish drugmaker on Friday abruptly announced that longtime CEO Lars ... of several of Novo Nordisk's other recent tie-ups. For example, Novo Nordisk in March said it had agreed to pay up ...

Drug maker Novo Nordisk (NVO) said on Friday that Lars Fruergaard Jørgensen will step down as CEO, sending shares down ... the Novo Nordisk Board has also agreed to let Lars Rebien Sørensen ...